Author Affiliations: Departments of Otolaryngology-Head and Neck Surgery (Dr Piccirillo), Neurology (Dr Duntley), and Medicine (Dr Schotland), and the Division of Pulmonary and Critical Care Medicine (Dr Schotland), Washington University School of Medicine, St Louis, Mo.
Obstructive sleep apnea (OSA) syndrome affects an estimated 2% to 4%
of the US adult population.1 It is part of
a collection of sleep-related breathing disorders, that include snoring, upper
airway resistance syndrome,2 and obesity-hypoventilation
syndrome.3 The clinical sequelae of untreated
OSA syndrome are often severe and include daytime hypersomnolence, cognitive
impairment, systemic hypertension, pulmonary hypertension, myocardial infarction,
cardiac arrhythmias, and increased risk of motor vehicle crashes.4,5 Unfortunately, the majority of patients
with OSA syndrome remain undiagnosed and untreated.6
Piccirillo JF, Duntley S, Schotland H. Obstructive Sleep Apnea. JAMA. 2000;284(12):1492–1494. doi:10.1001/jama.284.12.1492
Monkeypox Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.